🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Treatment Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could result in users administering substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several influencers attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and consumer regulations, risking fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has taken down violative material and banned related hashtags and search suggestions. The organization said it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive testimonials and detailed instructions for preparing or injecting at home.

Within minutes of joining one group, a vendor shared WhatsApp details, where most purchases take place. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts show black plastic parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Although the research behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her team has previously encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to possibly serious medical dangers”.